We are live on ! Find out more
CTOR

Citius Oncology
CTOR

13 hedge funds and large institutions have $43.8M invested in Citius Oncology in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

7% less capital invested

Capital invested by funds: $46.9M → $43.8M (-$3.12M)

13% less funds holding

Funds holding: 15 → 13 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LSC
Logan Stone Capital
Illinois
+$2.73M
2
CAC
Cowen and Company
New York
+$1.26M
3
MSU
Mizuho Securities USA
New York
+$140K
4
QL
Quarry LP
New York
+$2.24K
5
WRBC
W.R. Berkley Corp
Connecticut
+$2.24K

Top Sellers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
-$4.13M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
-$2.21M
3
SFM
Spartan Fund Management
Canada
-$1.83M
4
WAM
Wolverine Asset Management
Illinois
-$58.5K
5
GCL
Glazer Capital LLC
New York
-$51.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
1
Cowen and Company
New York
$7.12M +$1.26M +112,667 +22%
WRBC
2
W.R. Berkley Corp
Connecticut
$6.02M +$2.24K +200 +0%
WAM
3
Wolverine Asset Management
Illinois
$4.62M -$58.5K -5,219 -1%
RCM
4
Rivernorth Capital Management
Florida
$3.98M – – –
MSU
5
Mizuho Securities USA
New York
$3.86M +$140K +12,498 +4%
GCL
6
Glazer Capital LLC
New York
$3.48M -$51.2K -4,569 -1%
WCMNY
7
Westchester Capital Management (New York)
New York
$3.4M – – –
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$3.39M – – –
LSC
9
Logan Stone Capital
Illinois
$2.76M +$2.73M +243,158 New
YCM
10
Yakira Capital Management
Connecticut
$2.56M – – –
QL
11
Quarry LP
New York
$2.27M +$2.24K +200 +0.1%
VF
12
Virtu Financial
New York
$319K -$4.78K -426 -1%
TRCT
13
Tower Research Capital (TRC)
New York
$466 – – –
FTCM
14
First Trust Capital Management
Illinois
– -$4.13M -373,806 Closed
PAMP
15
Polar Asset Management Partners
Ontario, Canada
– -$2.21M -200,000 Closed
SFM
16
Spartan Fund Management
Canada
– -$1.83M -165,000 Closed

CTOR Hedge Fund Activity: Q2 2024 in Review

13 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q2 2024, worth a combined $43.8M — down 6.6% from $46.9M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CTOR and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was Logan Stone Capital, opening a new position worth an estimated $2.73M. The largest seller was First Trust Capital Management, exiting entirely with an estimated $4.13M sold.

  • 13 institutional investors held Citius Oncology (CTOR) as of Q2 2024, down from 15 in Q1 2024.
  • Funds reported $43.8M of Citius Oncology stock for Q2 2024, down 6.6% quarter-over-quarter.
  • 1 fund opened new Citius Oncology positions in Q2 2024 and 3 closed out, a net change of -2 holders.
  • The largest Citius Oncology buyer in Q2 2024 was Logan Stone Capital, an estimated $2.73M added.
  • The largest Citius Oncology seller in Q2 2024 was First Trust Capital Management, an estimated $4.13M sold.

Based on aggregated 13F filings for Q2 2024.